Biocom California’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom California has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
Close
Chief Business Officer, TRACON
Mr. Wiggins is Chief Business Officer at TRACON Pharmaceuticals since 2018. Prior to his current role he served as Senior Vice President of Corporate and Business Development at Elcelyx Therapeutics, and Chief Business Officer at Mpex Pharmaceuticals. Earlier he worked for eleven years at Executive Vice President of Corporate and Business Development at Biogen Idec, and Vice President of Marketing and Business Development at IDEC Pharmaceuticals. For ten years Mr. Wiggins also previously worked at Schering-Plough (now Merck), and Pfizer and Johnson & Johnson beforehand. Mr. Wiggins currently serves on the board of directors of Zogenix and SelectION. He received a B.S. in finance from Syracuse University and an M.B.A. from the University of Arizona.